比伐卢定-话题@MedSci

#比伐卢定#

19篇内容 | 741人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1667779, encodeId=2036166e77952, content=<a href='/topic/show?id=676c636260c' target=_blank style='color:#2F92EE;'>#比伐卢定#</a>, objectTitle=EUR HEART J-CARD PHA：经皮冠状动脉介入比伐卢定输注与净不良临床事件之间的关联？, objectType=article, longId=187477, objectId=947d18e47738, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=947d18e47738, replyNumber=0, likeNumber=43, createdTime=2020-12-23, rootId=0, userName=Luyuxie_18, userId=a96426178489, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=947d18e47738, moduleTitle=EUR HEART J-CARD PHA：经皮冠状动脉介入比伐卢定输注与净不良临床事件之间的关联？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=947d18e47738)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1667778, encodeId=81d5166e7785a, content=<a href='/topic/show?id=676c636260c' target=_blank style='color:#2F92EE;'>#比伐卢定#</a>, objectTitle=JACC：PCI术后输注比伐卢定可改善预后, objectType=article, longId=160789, objectId=000e160e89c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=000e160e89c8, replyNumber=0, likeNumber=45, createdTime=2019-09-04, rootId=0, userName=Luyuxie_18, userId=a96426178489, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=000e160e89c8, moduleTitle=JACC：PCI术后输注比伐卢定可改善预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=000e160e89c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1667776, encodeId=81bd166e776e2, content=<a href='/topic/show?id=676c636260c' target=_blank style='color:#2F92EE;'>#比伐卢定#</a>, objectTitle=欧洲血运重建指南：**经桡动脉路径，所有介入都应使用药物支架，新型口服抗凝药地位提升，比伐卢定地位下降, objectType=article, longId=147614, objectId=0d4814e61482, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0d4814e61482, replyNumber=0, likeNumber=44, createdTime=2019-02-09, rootId=0, userName=Luyuxie_18, userId=a96426178489, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0d4814e61482, moduleTitle=欧洲血运重建指南：**经桡动脉路径，所有介入都应使用药物支架，新型口服抗凝药地位提升，比伐卢定地位下降, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0d4814e61482)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1667777, encodeId=694a166e777f8, content=<a href='/topic/show?id=676c636260c' target=_blank style='color:#2F92EE;'>#比伐卢定#</a>, objectTitle=Lancet：桡动脉vs股动脉入径，比伐卢定vs肝素对急性冠状动脉综合征患者1年预后的影响, objectType=article, longId=148462, objectId=3f7b14846256, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3f7b14846256, replyNumber=0, likeNumber=45, createdTime=2019-04-14, rootId=0, userName=Luyuxie_18, userId=a96426178489, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3f7b14846256, moduleTitle=Lancet：桡动脉vs股动脉入径，比伐卢定vs肝素对急性冠状动脉综合征患者1年预后的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3f7b14846256)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1667775, encodeId=d296166e77554, content=<a href='/topic/show?id=676c636260c' target=_blank style='color:#2F92EE;'>#比伐卢定#</a>, objectTitle=AHJ：STEMI患者直接PCI抗凝：比伐卢定PK肝素, objectType=article, longId=138278, objectId=90fe1382e81a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=90fe1382e81a, replyNumber=0, likeNumber=38, createdTime=2018-07-06, rootId=0, userName=Luyuxie_18, userId=a96426178489, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=90fe1382e81a, moduleTitle=AHJ：STEMI患者直接PCI抗凝：比伐卢定PK肝素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=90fe1382e81a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1667774, encodeId=c625166e77459, content=<a href='/topic/show?id=676c636260c' target=_blank style='color:#2F92EE;'>#比伐卢定#</a>, objectTitle=JACC：急性冠脉综合征的治疗——比伐卢定 vs 肝素, objectType=article, longId=132810, objectId=b6b9132810cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b6b9132810cd, replyNumber=0, likeNumber=29, createdTime=2018-06-16, rootId=0, userName=Luyuxie_18, userId=a96426178489, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b6b9132810cd, moduleTitle=JACC：急性冠脉综合征的治疗——比伐卢定 vs 肝素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b6b9132810cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1667772, encodeId=4957166e772e6, content=<a href='/topic/show?id=676c636260c' target=_blank style='color:#2F92EE;'>#比伐卢定#</a>, objectTitle=JACC Cardiovasc Interv：经桡动脉PCI抗凝：比伐卢定真的比肝素更出色？, objectType=article, longId=104088, objectId=767010408818, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=767010408818, replyNumber=0, likeNumber=43, createdTime=2017-12-14, rootId=0, userName=Luyuxie_18, userId=a96426178489, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=767010408818, moduleTitle=JACC Cardiovasc Interv：经桡动脉PCI抗凝：比伐卢定真的比肝素更出色？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=767010408818)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1667773, encodeId=cf9b166e77397, content=<a href='/topic/show?id=676c636260c' target=_blank style='color:#2F92EE;'>#比伐卢定#</a>, objectTitle=N Engl J Med：心梗治疗：比伐卢定pk肝素, objectType=article, longId=116949, objectId=9536116949d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9536116949d8, replyNumber=0, likeNumber=33, createdTime=2017-11-18, rootId=0, userName=Luyuxie_18, userId=a96426178489, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9536116949d8, moduleTitle=N Engl J Med：心梗治疗：比伐卢定pk肝素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9536116949d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1667771, encodeId=7675166e77118, content=<a href='/topic/show?id=676c636260c' target=_blank style='color:#2F92EE;'>#比伐卢定#</a>, objectTitle=Cardiovasc Ther：STEMI患者PCI后全剂量比伐卢定灌注能否预防急性支架血栓？, objectType=article, longId=103440, objectId=dcde10344008, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dcde10344008, replyNumber=0, likeNumber=40, createdTime=2017-09-11, rootId=0, userName=Luyuxie_18, userId=a96426178489, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dcde10344008, moduleTitle=Cardiovasc Ther：STEMI患者PCI后全剂量比伐卢定灌注能否预防急性支架血栓？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dcde10344008)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1667770, encodeId=0c85166e770f6, content=<a href='/topic/show?id=676c636260c' target=_blank style='color:#2F92EE;'>#比伐卢定#</a>, objectTitle=BMJ：比伐卢定 vs 肝素治疗急性冠状动脉综合征患者，哪一个更好？, objectType=article, longId=78717, objectId=d8aee87172d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d8aee87172d, replyNumber=0, likeNumber=34, createdTime=2017-03-29, rootId=0, userName=Luyuxie_18, userId=a96426178489, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d8aee87172d, moduleTitle=BMJ：比伐卢定 vs 肝素治疗急性冠状动脉综合征患者，哪一个更好？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d8aee87172d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1667769, encodeId=fdce166e7693d, content=<a href='/topic/show?id=676c636260c' target=_blank style='color:#2F92EE;'>#比伐卢定#</a>, objectTitle=JACC：TAVR过程中，比伐卢定并不优于肝素的效果, objectType=article, longId=61019, objectId=d8e861019d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d8e861019d3, replyNumber=0, likeNumber=31, createdTime=2016-04-05, rootId=0, userName=Luyuxie_18, userId=a96426178489, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d8e861019d3, moduleTitle=JACC：TAVR过程中，比伐卢定并不优于肝素的效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d8e861019d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1667768, encodeId=25cf166e768e2, content=<a href='/topic/show?id=676c636260c' target=_blank style='color:#2F92EE;'>#比伐卢定#</a>, objectTitle=JAMA：治疗急性心肌梗死：比伐卢定VS肝素, objectType=article, longId=49115, objectId=9beb491157f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9beb491157f, replyNumber=0, likeNumber=36, createdTime=2015-12-05, rootId=0, userName=Luyuxie_18, userId=a96426178489, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9beb491157f, moduleTitle=JAMA：治疗急性心肌梗死：比伐卢定VS肝素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9beb491157f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1667766, encodeId=40b6166e76697, content=<a href='/topic/show?id=676c636260c' target=_blank style='color:#2F92EE;'>#比伐卢定#</a>, objectTitle=Circ Cardiovasc Interv：冠心病患者PCI后比伐卢定抗凝治疗真实世界研究证据（EVENT和EUROVISION注册研究）, objectType=article, longId=35769, objectId=497c35e692e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=497c35e692e, replyNumber=0, likeNumber=40, createdTime=2015-01-16, rootId=0, userName=Luyuxie_18, userId=a96426178489, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=497c35e692e, moduleTitle=Circ Cardiovasc Interv：冠心病患者PCI后比伐卢定抗凝治疗真实世界研究证据（EVENT和EUROVISION注册研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=497c35e692e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1667764, encodeId=b485166e76484, content=<a href='/topic/show?id=676c636260c' target=_blank style='color:#2F92EE;'>#比伐卢定#</a>, objectTitle=ESC-HF 2014：EUROMAX研究数据分析再次引发比伐卢定和肝素的争议, objectType=article, longId=35767, objectId=2e0835e6730, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2e0835e6730, replyNumber=0, likeNumber=42, createdTime=2015-03-06, rootId=0, userName=Luyuxie_18, userId=a96426178489, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e0835e6730, moduleTitle=ESC-HF 2014：EUROMAX研究数据分析再次引发比伐卢定和肝素的争议, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2e0835e6730)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1667765, encodeId=5ee9166e76502, content=<a href='/topic/show?id=676c636260c' target=_blank style='color:#2F92EE;'>#比伐卢定#</a>, objectTitle=ACC 2014：心梗患者直接PCI抗凝肝素完胜比伐卢定, objectType=article, longId=35768, objectId=cce835e681d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cce835e681d, replyNumber=0, likeNumber=29, createdTime=2014-08-29, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cce835e681d, moduleTitle=ACC 2014：心梗患者直接PCI抗凝肝素完胜比伐卢定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cce835e681d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1667767, encodeId=5d4a166e767d3, content=<a href='/topic/show?id=676c636260c' target=_blank style='color:#2F92EE;'>#比伐卢定#</a>, objectTitle=Eur Heart J：直接PCI转运期间比伐卢定优于肝素联合GPI, objectType=article, longId=36181, objectId=f3a736181ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f3a736181ef, replyNumber=0, likeNumber=44, createdTime=2014-07-07, rootId=0, userName=Luyuxie_18, userId=a96426178489, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f3a736181ef, moduleTitle=Eur Heart J：直接PCI转运期间比伐卢定优于肝素联合GPI, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f3a736181ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1667763, encodeId=410d166e763cd, content=<a href='/topic/show?id=676c636260c' target=_blank style='color:#2F92EE;'>#比伐卢定#</a>, objectTitle=NEJM：EUROMAX研究表明拟行PCI手术患者转运途中使用比伐卢定可降低大出血及死亡风险, objectType=article, longId=26240, objectId=6db026240c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6db026240c2, replyNumber=0, likeNumber=41, createdTime=2014-07-27, rootId=0, userName=Luyuxie_18, userId=a96426178489, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6db026240c2, moduleTitle=NEJM：EUROMAX研究表明拟行PCI手术患者转运途中使用比伐卢定可降低大出血及死亡风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6db026240c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1667761, encodeId=fc8d166e7614f, content=<a href='/topic/show?id=676c636260c' target=_blank style='color:#2F92EE;'>#比伐卢定#</a>, objectTitle=NEJM：阿昔单抗和肝素与比伐卢定治疗非ST段抬高心肌梗死的效果比较, objectType=article, longId=3393, objectId=ca7b339391, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca7b339391, replyNumber=0, likeNumber=43, createdTime=2012-10-09, rootId=0, userName=Luyuxie_18, userId=a96426178489, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca7b339391, moduleTitle=NEJM：阿昔单抗和肝素与比伐卢定治疗非ST段抬高心肌梗死的效果比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ca7b339391)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1667762, encodeId=008b166e7627f, content=<a href='/topic/show?id=676c636260c' target=_blank style='color:#2F92EE;'>#比伐卢定#</a>, objectTitle=Circulation：ACUITY研究显示比伐卢定单药治疗安全降低ACS患者出血风险, objectType=article, longId=4189, objectId=7b264189a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7b264189a4, replyNumber=0, likeNumber=38, createdTime=2012-11-11, rootId=0, userName=Luyuxie_18, userId=a96426178489, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7b264189a4, moduleTitle=Circulation：ACUITY研究显示比伐卢定单药治疗安全降低ACS患者出血风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7b264189a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

比伐卢定

2020-05-29

Luyuxie_18 (审核中...)

前往app查看评论内容

#比伐卢定#

EUR HEART J-CARD PHA：经皮冠状动脉介入比伐卢定输注与净不良临床事件之间的关联？

2020-12-23

Luyuxie_18 (审核中...)

前往app查看评论内容

#比伐卢定#

JACC：PCI术后输注比伐卢定可改善预后

2019-09-04

Luyuxie_18 (审核中...)

前往app查看评论内容

#比伐卢定#

欧洲血运重建指南：**经桡动脉路径，所有介入都应使用药物支架，新型口服抗凝药地位提升，比伐卢定地位下降

2019-02-09

Luyuxie_18 (审核中...)

前往app查看评论内容

#比伐卢定#

Lancet：桡动脉vs股动脉入径，比伐卢定vs肝素对急性冠状动脉综合征患者1年预后的影响

2019-04-14

Luyuxie_18 (审核中...)

前往app查看评论内容

#比伐卢定#

AHJ：STEMI患者直接PCI抗凝：比伐卢定PK肝素

2018-07-06

Luyuxie_18 (审核中...)

前往app查看评论内容

#比伐卢定#

JACC：急性冠脉综合征的治疗——比伐卢定 vs 肝素

2018-06-16

Luyuxie_18 (审核中...)

前往app查看评论内容

#比伐卢定#

JACC Cardiovasc Interv：经桡动脉PCI抗凝：比伐卢定真的比肝素更出色？

2017-12-14

Luyuxie_18 (审核中...)

前往app查看评论内容

#比伐卢定#

N Engl J Med：心梗治疗：比伐卢定pk肝素

2017-11-18

Luyuxie_18 (审核中...)

前往app查看评论内容

#比伐卢定#

Cardiovasc Ther：STEMI患者PCI后全剂量比伐卢定灌注能否预防急性支架血栓？

2017-09-11

Luyuxie_18 (审核中...)

前往app查看评论内容

#比伐卢定#

BMJ：比伐卢定 vs 肝素治疗急性冠状动脉综合征患者，哪一个更好？

2017-03-29

Luyuxie_18 (审核中...)

前往app查看评论内容

#比伐卢定#

JACC：TAVR过程中，比伐卢定并不优于肝素的效果

2016-04-05

Luyuxie_18 (审核中...)

前往app查看评论内容

#比伐卢定#

JAMA：治疗急性心肌梗死：比伐卢定VS肝素

2015-12-05

Luyuxie_18 (审核中...)

前往app查看评论内容

#比伐卢定#

Circ Cardiovasc Interv：冠心病患者PCI后比伐卢定抗凝治疗真实世界研究证据（EVENT和EUROVISION注册研究）

2015-01-16

Luyuxie_18 (审核中...)

前往app查看评论内容

#比伐卢定#

ESC-HF 2014：EUROMAX研究数据分析再次引发比伐卢定和肝素的争议

2015-03-06

柳叶一刀 (审核中...)

前往app查看评论内容

#比伐卢定#

ACC 2014：心梗患者直接PCI抗凝肝素完胜比伐卢定

2014-08-29

Luyuxie_18 (审核中...)

前往app查看评论内容

#比伐卢定#

Eur Heart J：直接PCI转运期间比伐卢定优于肝素联合GPI

2014-07-07

Luyuxie_18 (审核中...)

前往app查看评论内容

#比伐卢定#

NEJM：EUROMAX研究表明拟行PCI手术患者转运途中使用比伐卢定可降低大出血及死亡风险

2014-07-27

Luyuxie_18 (审核中...)

前往app查看评论内容

#比伐卢定#

NEJM：阿昔单抗和肝素与比伐卢定治疗非ST段抬高心肌梗死的效果比较

2012-10-09

Luyuxie_18 (审核中...)

前往app查看评论内容

#比伐卢定#

Circulation：ACUITY研究显示比伐卢定单药治疗安全降低ACS患者出血风险

2012-11-11

科室
- - 订阅+
  - 更多科室
工具
服务